WHAT’S NEW IN IBD? UPDATED TREATMENT ALGORITHM IN CD AND UC

About Webinar

This focused webinar offers an up-to-date overview of recent developments in the treatment algorithms for Crohn’s disease (CD) and ulcerative colitis (UC). Featuring expert insights from leading IBD specialists, the session will examine the evolving therapeutic landscape, with particular attention to the role of IL-23 inhibitors and the integration of new agents such as guselkumab into clinical practice. Moderated by Professors Silvio Danese and Laurent Peyrin-Biroulet, the webinar aims to provide clinicians with practical guidance on how to navigate current options and optimize individualized care for IBD patients.

Topic discussed

The session will begin with a comparative analysis of IL-23 inhibitors, addressing whether these agents offer similar efficacy and safety profiles or if key distinctions should influence treatment selection. The discussion will then explore how guselkumab fits into the updated treatment algorithm for both ulcerative colitis and Crohn’s disease, highlighting clinical evidence, patient profiles, and decision-making criteria. A concluding Q&A with all faculty members will allow for deeper engagement on the practical application of these insights in daily IBD management.